FDA warns of rare stroke risk with MS drug

December 5, 2018

(HealthDay)—A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said.

Most patients with these problems—which can lead to permanent disability and death—developed symptoms within a day of receiving an initial infusion of Lemtrada, the agency said. In one patient, symptoms occurred three days after receiving the drug.

One MS specialist said the information is important to people with MS, but it shouldn't mean they must immediately stop using the drug.

"One must always weigh the risks and benefits of treatment in relation to the risk of the underlying disease process," said Dr. Asaff Harel, a neurologist at Lenox Hill Hospital in New York City. He said that for many patients, Lemtrada is a really effective therapy, so "the benefits may outweigh for some patients."

In the meantime, the FDA said it is mandating a new warning about these risks to the prescribing information on the drug label and to the patient Medication Guide. The risk of stroke has also been added to the existing boxed warning, the agency said.

Alemtuzumab is also approved under the brand name Campath to treat a type of cancer called B-cell chronic lymphocytic leukemia (B-CLL). The label of that will also be updated to include the risk of stroke and tears in the lining of the head (arterial dissection), the FDA said.

If patients taking alemtuzumab develop signs or symptoms of a stroke or arterial dissection, they or their caregivers must seek as soon as possible.

Symptoms can include: sudden numbness or weakness in the face, arms, or legs, especially on only one side of the body; sudden confusion, trouble speaking, or difficulty understanding speech; sudden trouble seeing in one or both eyes; sudden trouble with walking, dizziness, or loss of balance or coordination; sudden severe headache or neck pain.

At every Lemtrada infusion, should advise to seek immediate emergency medical help if they develop symptoms of stroke or arterial dissection, the FDA said.

Explore further: One in three American adults may have had a warning stroke

More information: The U.S. National Institute of Neurological Disorders and Stroke has more on multiple sclerosis.

Related Stories

One in three American adults may have had a warning stroke

May 1, 2017
About one in three American adults experienced a symptom consistent with a warning or "mini" stroke, but almost none - 3 percent - took the recommended action, according to a new survey from the American Heart Association/American ...

FDA warns heart patients about antibiotic clarithromycin

February 23, 2018
(HealthDay)—The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.

What you need to know about strokes

May 12, 2018
(HealthDay)—Stroke is the leading cause of preventable death in the United States, but a lack of awareness and resources hinder efforts to change that, the American Stroke Association says.

JAMA study finds patients with stroke symptoms are still not calling 911

March 14, 2012
Nationwide ambulance use by patients suffering from a stroke has not changed since the mid-1990s, even though effective stroke treatments are now available. In a study published in this week's Journal of the American Medical ...

Recommended for you

Research team traces pathway to cardioprotection in post-ischemic heart failure

December 11, 2018
During an ischemic attack, the heart is temporarily robbed of its blood supply. The aftermath is devastating: reduced heart contractility, heart cell death, and heart failure. Contributing to these detrimental changes is ...

Study reveals new link between atrial fibrillation and mutations in heart disease gene

December 11, 2018
Atrial fibrillation (Afib), a heart condition that causes a rapid, irregular heartbeat that increases a person's risk of stroke and heart failure, is fairly common among older adults. However, its early onset form is relatively ...

Macrophage cells key to helping heart repair—and potentially regenerate, new study finds

December 11, 2018
Scientists at the Peter Munk Cardiac Centre have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Study: Age, race differences determine risk of stroke in women and men

December 11, 2018
A new study found that, between the ages of 45 and 74 years, white women were less likely to have a stroke than white men, but at age 75 and older, there was no difference in stroke risk between white women and men. In contrast, ...

Possible connection between cardiovascular disease and living near oil and gas wells

December 11, 2018
Researchers at the Colorado School of Public Health have found a possible connection between the intensity of oil and gas exploration in an area and early indicators of cardiovascular disease among nearby residents.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.